# Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control

> **NCT03613688** · NA · UNKNOWN · sponsor: **Tasly Pharmaceuticals, Inc.** · enrollment: 28 (estimated)

## Conditions studied

- Glucose Metabolism Disorders

## Interventions

- **DIETARY_SUPPLEMENT:** Deepure

## Key facts

- **NCT ID:** NCT03613688
- **Lead sponsor:** Tasly Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-20
- **Primary completion:** 2019-06
- **Final completion:** 2019-07
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2018-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03613688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03613688, "Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03613688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*